Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

  1. Sanz, M.A.
  2. Montesinos, P.
  3. Vellenga, E.
  4. Rayón, C.
  5. De La Serna, J.
  6. Parody, R.
  7. Bergua, J.M.
  8. León, A.
  9. Negri, S.
  10. González, M.
  11. Rivas, C.
  12. Esteve, J.
  13. Milone, G.
  14. González, J.D.
  15. Amutio, E.
  16. Brunet, S.
  17. García-Laraña, J.
  18. Colomer, D.
  19. Calasanz, M.J.
  20. Chillón, C.
  21. Barragán, E.
  22. Bolufer, P.
  23. Lowenberg, B.
Aldizkaria:
Blood

ISSN: 0006-4971,  1528-0020

Argitalpen urtea: 2008

Alea: 112

Zenbakia: 8

Orrialdeak: 3130-3134

Mota: Artikulua

DOI: 10.1182/BLOOD-2008-05-159632 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus